Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
3.320
-0.300 (-8.29%)
At close: Dec 5, 2025, 4:00 PM EST
3.270
-0.050 (-1.51%)
After-hours: Dec 5, 2025, 7:59 PM EST
Q32 Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 12.17, with a low estimate of 3.00 and a high estimate of 22. The average target predicts an increase of 266.57% from the current stock price of 3.32.
Analyst Consensus: Hold
* Price targets were last updated on Mar 12, 2025.
Analyst Ratings
The average analyst rating for Q32 Bio stock from 7 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 3 | 3 | 3 | 3 | 3 | 2 |
| Hold | 5 | 5 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $16 → $15 | Hold | Maintains | $16 → $15 | +351.81% | Mar 12, 2025 |
| BMO Capital | BMO Capital | Buy → Hold Downgrades $22 → $3 | Buy → Hold | Downgrades | $22 → $3 | -9.64% | Feb 11, 2025 |
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $20 → $4 | Buy → Hold | Downgrades | $20 → $4 | +20.48% | Feb 11, 2025 |
| BMO Capital | BMO Capital | Buy Maintains $64 → $22 | Buy | Maintains | $64 → $22 | +562.65% | Dec 12, 2024 |
| Guggenheim | Guggenheim | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Dec 12, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.81
from -6.58
EPS Next Year
-5.70
from -2.81
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -2.27 | -1.19 | |
| Avg | -2.81 | -5.70 | |
| Low | -3.28 | -9.85 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.